Sage Journals: Discover world-class research

Open access

Research article

First published 2018

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients

Joep J. de Jong, Kees Hendricksen, Marloes Rosier [...]

Bladder Cancer

Open access

Research article

First published 2019

A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer

Michael A. O’Donnell, Sharwan Singh, Rajeev Sood [...]

Bladder Cancer

Open access

Review article

First published 2023

New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer

Anastasios D. Asimakopoulos, Maxim Kochergin, Gaia Colalillo [...]

Bladder Cancer

Open access

Review article

First published

Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease

Ryan L. Steinberg, Lewis J. Thomas, Michael A. O’Donnell

Bladder Cancer

Open access

Review article

First published 2024

Clinical use of nadofaragene firadenovec-vncg

Badrinath R. Konety, Neal D. Shore, Grannum R. Sant

Therapeutic Advances in Urology

Open access

Review article

First published 2021

Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma

Omid Yassaie, Cyrus Chehroudi, Peter C. Black

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Outcomes of Patients with Bacillus Calmette-Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug Administration

Jeffrey M. Howard, Grayden S. Cook, Aaron Tverye [...]

Bladder Cancer

Open access

Review article

First published 2025-6

Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer

Clarissa M Gurbani, Yew-Lam Chong, Zhen Wei Choo [...]

Bladder Cancer

Open access

Review article

First published 2025-4

Practical use of nadofaragene firadenovec-vncg for pharmacists

Seth D Holler, Sara Moran Smith

Journal of Oncology Pharmacy Practice

Open access

Letter

First published 2017

Once BCG Unresponsive,Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer

Ashish M. Kamat, Seth Lerner, Peter Black [...]

Bladder Cancer

Search results